1-15 of 696
Navigating AKT Inhibitor-Associated Adverse Events in HR+/HER2- Advanced Breast Cancer
Project Oncology®Navigating AKT Inhibitor-Associated Adverse Events in HR+/HER2- Advanced Breast Cancer
Alexandria May, PharmD, BCPS
Adam Brufsky, MD, PhD
Managing AKT Inhibitor-Associated AEs in HR+/HER2- Advanced Breast Cancer
Project Oncology®Managing AKT Inhibitor-Associated AEs in HR+/HER2- Advanced Breast Cancer
Charles Turck, PharmD, BCPS, BCCCP
Neil M. Iyengar, MD
Sarah H. Donahue, MPH, NP
How Colorectal Cancer Screening Fits into OB/GYN Care
Clinician's RoundtableHow Colorectal Cancer Screening Fits into OB/GYN Care
Mallik Greene, PhD
Adherence to OB/GYN-Ordered CRC Screening: Real-World Insights
Clinician's RoundtableAdherence to OB/GYN-Ordered CRC Screening: Real-World Insights
Mallik Greene, PhD
Streamlining Colorectal Cancer Screening in OB/GYN Care
Clinician's RoundtableStreamlining Colorectal Cancer Screening in OB/GYN Care
Jemel Bingham, MD
Why Adenoma Detection Rate Matters in Colorectal Cancer Screening
Clinician's RoundtableWhy Adenoma Detection Rate Matters in Colorectal Cancer Screening
Brian P. McDonough, MD, FAAFP
Renee Williams, MD, GI
- advertisement
Protecting Heart Health in Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerProtecting Heart Health in Metastatic Breast Cancer
Ryan Quigley
Gregory Vidal, MD, PhD
The Past, Present, and Future of Metastatic Breast Cancer Care
On the Frontlines of Metastatic Breast CancerThe Past, Present, and Future of Metastatic Breast Cancer Care
Ryan Quigley
Gregory Vidal, MD, PhD
Proactive Pregnancy Planning and Reproductive Care in MS
NeuroFrontiersProactive Pregnancy Planning and Reproductive Care in MS
Riley Bove, MD, MMSc
Family Planning in Patients with Multiple Sclerosis
NeuroFrontiersFamily Planning in Patients with Multiple Sclerosis
Decoding Co-Mutations in HR+, HER2- Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerDecoding Co-Mutations in HR+, HER2- Metastatic Breast Cancer
Abirami Sivapiragasam
Assessing G-CSF Prophylaxis with Sacituzumab Govitecan in mTNBC
Project Oncology®Assessing G-CSF Prophylaxis with Sacituzumab Govitecan in mTNBC
Charles Turck, PharmD, BCPS, BCCCP
Kelly McCann, MD, PhD
Gregory Vidal, MD, PhD
- advertisement
Addressing Unmet Needs in First-Line mTNBC Care
On the Frontlines of Metastatic Breast CancerAddressing Unmet Needs in First-Line mTNBC Care
Jennifer Caudle, DO, FACOFP
Alexis Ann LeVee, MD
Expanding the Role of Hormonal Therapy and Isotretinoin in Acne Care
Clinician's RoundtableExpanding the Role of Hormonal Therapy and Isotretinoin in Acne Care
John Barbieri, MD, MBA, FAAD
Biomarker-Guided Treatment in ER+, HER2- Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerBiomarker-Guided Treatment in ER+, HER2- Metastatic Breast Cancer
Maxwell Llyod, MD
Ryan Quigley
